High-density lipoprotein (HDL) cholesterol concentrations are inversely associated with cardiovascular disease and mortality across a range of concentrations, but genetic evidence suggest that extreme high concentrations may paradoxically lead to more cardiovascular disease. We tested the hypothesis that extreme high concentrations of HDL cholesterol are associated with high all-cause mortality in men and women. 
Introduction
Through observational studies it has been established that highdensity lipoprotein (HDL) cholesterol is inversely associated with both cardiovascular disease and mortality across a wide range of concentrations. [1] [2] [3] This association does however not appear to be causal, as raising HDL cholesterol pharmacologically has not proven beneficial in randomized clinical trials, 4 and has even paradoxically been associated with increased mortality in one study. 5 Furthermore, certain genetic variants associated with higher concentrations of HDL cholesterol have been associated paradoxically with high risk of cardiovascular disease. [6] [7] [8] One of these studies refers to elevated HDL cholesterol associated with a polymorphism of the CETP gene leading to low activity of the cholesteryl ester transfer dications that extreme high HDL cholesterol concentrations might not be associated with low morbidity and mortality, the association between extreme high HDL cholesterol and mortality is not welldescribed. This is in part because only few individuals have extremely high HDL cholesterol concentrations 11 and therefore often are grouped together with individuals with only modestly high concentrations, in for example quintiles. 1 If those with extreme high HDL cholesterol have high mortality, like those with low concentrations, this could have implications for clinical risk assessment in those with extreme high concentrations of HDL cholesterol, and consequences for development of compounds aimed at increasing HDL concentrations. We tested the hypothesis that men and women with extreme high HDL cholesterol have high all-cause mortality, using two separate studies of the Danish general population. Furthermore, we determined the concentration of HDL cholesterol associated with the lowest all-cause mortality.
Methods
A detailed description of endpoints, covariates and statistical analyses is given in the Supplementary material online, Appendix (Methods).
Study cohorts
White individuals of Danish descent (according to the Danish Civil Registration System, that is, the person and both parents were born in Denmark and were Danish citizens) were included from two studies of the Danish general population. Written informed consent was obtained from all. Studies were conducted in accordance with the Declaration of Helsinki and approved by local institutional reviews boards and Danish Ethics Committees (KF-100.2039/91 and H-KF-01-144/01).
The Copenhagen City Heart Study (CCHS)
Individuals aged 20-100 years were invited randomly from the general population of Copenhagen using information from the Danish Civil Registration System. Information on health, lifestyle etc. was obtained from questionnaires, which were reviewed with an investigator on the day of attendance, and from a physical examination. Blood was drawn for biochemical measurements. For this study 9387 individuals from the 1991 to 1994 examination of the CCHS were included (participation rate, 61%). 12 The Copenhagen General Population Study (CGPS)
The study was initiated in 2003 with ongoing recruitment similar to that of the CCHS, but from a geographically separate area around Copenhagen. No individuals were included in both studies. Examinations were conducted as described for the CCHS. 107 121 individuals were included from the CGPS (participation rate, 43%). 13 
Endpoints
Death from any cause was ascertained using the Danish Civil Registration System and the cause of death was retrieved from the Danish Register of Causes of Death. For this study, cause of death was classified into three major categories, as done previously. 14 
Laboratory analyses
Blood samples were collected non-fasting. 15 HDL cholesterol and triglycerides were measured using colorimetric assays (Konelab). LDL cholesterol was calculated using the Friedewald equation when triglycerides were below 4 mmol/L (352 mg/dL) or otherwise measured directly (Konelab).
Covariates
Covariates for statistical adjustment were chosen a priori according to known associations with all-cause mortality and HDL cholesterol and included: age, study, body mass index, current smoking, cumulative tobacco smoking, alcohol consumption, physical activity, systolic blood pressure, diabetes mellitus, lipid-lowering therapy, LDL cholesterol, triglycerides, birth year, and menopausal status and hormone replacement therapy for women.
Statistical analyses
Statistical analyses were performed using Stata 13.1. Missing information on covariates was imputed based on age and sex using multivariable linear regression for continuous variables, whereas categorical variables where assigned a separate category. The association between HDL cholesterol and endpoints was examined using Cox proportional hazards regression with 95% confidence intervals (CI) and age as the underlying time scale (referred to as age adjustment) with delayed entry (left truncation) and censoring at emigration (n = 478 (0.4%)) or end of follow-up. As women on average have higher concentrations of HDL cholesterol, analyses were conducted separately for men and women.
In primary analyses, the association between mortality and HDL cholesterol on a continuous scale was examined using restricted cubic splines incorporated in Cox proportional hazards models. The concentration of HDL cholesterol associated with the lowest mortality was the concentration with the lowest hazard ratio in the spline Cox regression. 95% CIs were non-parametric from bootstrap estimation with 5000 repetitions, as done previously. 14 The association between extreme high concentrations of HDL cholesterol and mortality was further examined using a priori selected groups of clinically meaningful HDL cholesterol concentrations. These were concentration cut points with 0.5 mmol/L intervals starting from 1.0 mmol/L. For men the highest group was > _3.0 mmol/L, and as women on average have higher HDL cholesterol than men, the highest group for women was > _3.5 mmol/L. Individuals were also divided into predefined groups based on percentiles. Reference groups were the ones containing the concentration of HDL cholesterol associated with the lowest risk of death determined using multifactorially adjusted spline regression.
Risk estimates and confidence intervals were corrected for regression dilution bias using a non-parametric method, 16 as done previously. 17, 18 Regression dilution is a phenomenon where random measurement error and long-term fluctuations in the exposure variable will lead to 
Results
A total of 52 268 men and 64 240 women were included from the CGPS and CCHS combined and were followed for 745 452 personyears. Median follow-up was 6.0 years (range: 0-23), with 5.7 years (0-11), and 19.9 years (0-23) for the CGPS and CCHS, respectively. During follow-up, 5619 men and 5059 women died from any cause giving crude mortality rates of 17.1 (95% CI: 16.7-17.6) and 12.1 (11.8-12.4) per 1000 person-years. Baseline characteristics for men and women separately are shown in Table 1 and further divided by study and concentration cut points in Supplementary material online, Tables S2, S3 , S4, and S5.
The distribution of HDL cholesterol concentrations in the general population was wider for women compared with the distribution in men, and on average women had higher HDL cholesterol ( Figure 1) . The distributions were similar in the two studies (Supplementary material online, Figure S1 ).
HDL cholesterol and all-cause mortality
The association between HDL cholesterol on a continuous scale and all-cause mortality was U-shaped for men and women, as both low and high concentrations were associated with high all-cause mortality ( Figure 2) . The association between extreme high HDL cholesterol and high mortality was most pronounced for men. The concentration of HDL cholesterol associated with the lowest all-cause mortality in men was 1.9 mmol/L (95% CI: 1.4-2.0 mmol/L) (73 mg/dL (54-77 mg/ dL)) in age and study adjusted analyses, 1.9 mmol/L (1.4-2.0 mmol/L) (73 mg/dL (54-77 mg/dL)) in age, study, and triglyceride adjusted analyses, and 1.9 mmol/L (1.1-2.0 mmol/L) (73 mg/dL (42-77 mg/dL)) in multifactorially adjusted analyses. For women the corresponding concentrations of HDL cholesterol associated with the lowest all-cause mortality were 2.4 mmol/L (1.8-2.5 mmol/L) (93 mg/dL (69-97 mg/ dL)), 2.4 mmol/L (1.8-2.5 mmol/L) (93 mg/dL (69-97 mg/dL)), and 2.4 mmol/L (1.7-6.2 mmol/L) (93 mg/dL (66-239 mg/dL)), respectively. For the multifactorially adjusted analyses in women the upper CI limit could not be definitively determined.
Similar to restricted cubic spline analyses, a U-shaped association between HDL cholesterol and all-cause mortality was seen in both sexes using concentration cut points ( In percentile-based analyses, multifactorially adjusted hazard ratios for all-cause mortality for the top percentile (100th) were 1.94 (1.47-2.55) for men and 1.36 (0.99-1.85) for women, when compared with men and women in the reference groups (81st-95th percentile).
HDL cholesterol and cause-specific mortality
A U-shaped association between HDL cholesterol and cardiovascular mortality was also seen for both men and women ( Figure 4) . For cancer mortality, lower concentrations of HDL cholesterol were associated with high risk in both sexes. Risk of other mortality showed a U-shaped association with HDL cholesterol in men, but no association in women. These findings were confirmed when using concentration cut points (Supplementary material online, Figure S2 ). The extreme high HDL group in both men and women had high cardiovascular mortality with multifactorially adjusted hazard ratios of 2.53 (95% CI: 1. from the Copenhagen General Population Study and the Copenhagen City Heart Study combined. Hazard ratio (solid line) and 95% confidence interval (dashed lines) from Cox regression using restricted cubic splines. Multifactorial adjustment was for age, study, body mass index, current smoking, cumulative tobacco smoking, alcohol consumption, physical activity, systolic blood pressure, diabetes mellitus, lipid-lowering therapy, LDL cholesterol, triglycerides, birth year, and menopausal status and hormone replacement therapy for women. The concentration of HDL cholesterol associated with lowest mortality was used as reference. Graphs were truncated at 0.4 and 4.0 mmol/L due to limited number of individuals and events outside these cutpoints. The light blue area indicates the distribution of HDL cholesterol concentrations in men and women. CI, confidence interval; HDL, high-density lipoprotein.
Extreme high HDL cholesterol and high mortality Based on 52 268 men and 64 240 women from the Copenhagen General Population Study and the Copenhagen City Heart Study combined. Hazard ratios from Cox regression were adjusted for age and study or multifactorially for age, study, body mass index, current smoking, cumulative tobacco smoking, alcohol consumption, physical activity, systolic blood pressure, diabetes mellitus, lipid-lowering therapy, LDL cholesterol, triglycerides, birth year, and menopausal status and hormone replacement therapy for women. Reference groups were the one containing HDL cholesterol concentrations associated with lowest all-cause mortality determined by multifactorially adjusted spline regressions. CI, confidence interval; HDL, high-density lipoprotein. 
HDL cholesterol and cardiovascular disease
For cardiovascular disease endpoints ischaemic heart disease and myocardial infarction, a high risk was observed for low concentrations of HDL cholesterol ( Figure 5 ). There was a plateau around HDL cholesterol of 1.5 mmol/L (58 mg/dL) and 2.0 mmol/L (77 mg/dL) for men and women, respectively, with no further decrease in risk with concentrations of HDL cholesterol higher than that. No significant increase in these risks were observed with extreme high concentrations of HDL cholesterol. For ischaemic stroke similar patterns of association were observed.
Sensitivity analyses
Results from complete-case analyses including only individuals with complete information on all covariates were similar to analyses using the full dataset (compare Figure 3 with Supplementary material online, Figure S3 ). Individuals included in the main analyses were combined from two independent studies; however, results were similar for the two studies separately (compare Figure 3 with Supplementary material online, Figure S4 ). Hence, we were able to obtain confirmation of the results in two independent studies.
Results for the extreme high HDL cholesterol group vs. the reference group were robust across different strata of risk factors for allcause mortality and medication use affecting all-cause mortality (Supplementary material online, Figures S5 and S6) . However, number of individuals and events were small in some extreme groups in stratified analyses generating risk estimates with wide CIs. There was, however, no clear evidence for statistical interaction in the stratified analyses.
To assess possible effects of reverse causation from severe disease likely leading to death and high HDL cholesterol, we examined association with all-cause mortality for the extreme high HDL vs. the reference group excluding individuals with less than 1 to 5 years of follow-up (Supplementary material online, Figure S7 ). Overall hazard ratios were similar, except for a slight attenuation for women when excluding those with less than 4 and 5 years of follow-up, indicating men and 64 240 women from the Copenhagen General Population Study and the Copenhagen City Heart Study combined. Hazard ratio (solid line) and 95% confidence interval (dashed lines) were from Cox regression using restricted cubic splines. Analyses were multifactorially adjusted for age, study, body mass index, current smoking, cumulative tobacco smoking, alcohol consumption, physical activity, systolic blood pressure, diabetes mellitus, lipid-lowering therapy, LDL cholesterol, triglycerides, birth year, and menopausal status and hormone replacement therapy for women. The HDL cholesterol concentration associated with the lowest cause specific mortality was used as reference. Graphs were truncated at 0.4 and 4.0 mmol/L due to limited number of individuals and events outside these cutpoints. Total number of deaths from the three categories does not add up to the total number of deaths by any cause, as not all deaths was classified according to cause, as described in Methods. The light blue area indicates the distribution of HDL cholesterol concentrations in men and women. CI, confidence interval; HDL, high-density lipoprotein.
Extreme high HDL cholesterol and high mortality that results were not caused by reverse causation. Analyses of causespecific mortality using underlying cause of death resulted in more deaths being classified as other mortality, however, results were similar to the primary analyses (compare Figure 4 with Supplementary material online, Figure S8 ).
Discussion
In this study of 116 508 individuals from the general population, the association between HDL cholesterol and all-cause mortality was Ushaped, with both extreme high and low HDL cholesterol concentrations being associated with high mortality (Summarizing Figure) . The same was observed in men with moderately elevated HDL cholesterol. The HDL cholesterol concentration associated with the lowest risk of all-cause mortality was 1.9 mmol/L (73 mg/dL) for men, and 2.4 mmol/L (93 mg/dL) for women, which are novel findings.
A possible explanation for the association between extreme high HDL cholesterol and higher mortality is that extreme high concentrations often are due to genetic variants. 19 Genetic variants may have detrimental effects causing high risk of disease and death, which is the case for certain mutations in CETP, ABCA1, LIPC, and SCARB1, which are associated with both high risk of coronary heart disease and high concentrations of HDL cholesterol. [6] [7] [8] 10 These studies, done mainly in the Copenhagen City Heart Study, only overlap with 10-20% of individuals included in the present study, where the majority of individuals were from the Copenhagen General Population Study. The observed associations in this study could also be an epiphenomenon where there is a pathophysiologic abnormality, perhaps genetic, which increases risk in ways we do not understand and also increases HDL, suggesting that the physiology of HDL is complex and perhaps not well understood. Conformation and functional properties of the HDL particle may also be altered in individuals with extreme high HDL cholesterol and an alternative hypothesis could be that in individuals with extreme high HDL cholesterol, the functionality of HDL may be compromised such that HDL no longer function normally but rather cause harm. Another possible explanation includes differences in risk factors associated with both high HDL cholesterol and mortality. Although our multifactorially adjusted analyses included the most important risk factors for all-cause mortality, 20 Figure 5 HDL cholesterol on a continuous scale and risk of ischaemic heart disease, myocardial infarction, and ischaemic stroke in the general population. Based on men and women from the Copenhagen General Population Study and the Copenhagen City Heart Study combined. Number of individuals included in the different analyses varies, as individuals with events before baseline were excluded for the three endpoints, respectively. Hazard ratio (solid line) and 95% confidence interval (dashed lines) were from Cox regression using restricted cubic splines. Analyses were multifactorially adjusted for age, study, body mass index, current smoking, cumulative tobacco smoking, alcohol consumption, physical activity, systolic blood pressure, diabetes mellitus, lipid-lowering therapy, LDL cholesterol, triglycerides, birth year, and menopausal status and hormone replacement therapy for women. The HDL cholesterol concentration associated with the lowest risk was used as reference, except for the endpoint ischaemic stroke in men, where the median value was used as the lowest risk was observed at the extreme high end. residual confounding cannot be discarded completely. Whether the association between extreme high HDL cholesterol and increased mortality is causal is an important unresolved question in relation to the findings in this study. Most observational studies investigating the association between HDL cholesterol and mortality have categorized individuals in larger groups, such as quintiles, and focus has been on low concentrations of HDL cholesterol, thereby failing to elucidate associations at extreme high concentrations. Two recently published studies based on routinely collected health data support our findings, as they indicated that the association between HDL cholesterol and mortality is not linear over the entire concentration range of HDL cholesterol. 21, 22 23 Our results indicate that the common belief that, the higher the concentration of HDL cholesterol the better, does not hold for extreme high concentrations, as the relationship between HDL cholesterol and all-cause mortality was not linear over the entire range of HDL concentrations. Secondly, if the association between extreme high HDL cholesterol and high risk of death is causal, these findings would add to the uncertainty regarding elevating HDL cholesterol pharmacologically to extreme high concentrations. Some of the developed CETP inhibitors can increase HDL cholesterol to extreme high concentrations, 24 that in this study were associated with higher mortality. Interestingly, the development of the CETP inhibitor torcetrapib was discontinued as it increased mortality, although this could be due to off-target effects. 5 However, the present findings point toward an alternative explanation, namely that extreme high HDL cholesterol could in itself be the cause of high mortality. As this study was observational, it could not determine if the association between extreme high HDL cholesterol and higher mortality was causal. The association may be due to unmeasured confounding or reverse causation. However, results from analyses excluding individuals dying within the first 1 to 5 years of follow-up did not seem to indicate reverse causation. Another limitation was the relative rarity of extremely high HDL concentrations; however, the 2.5% of men with the highest HDL cholesterol were all at increased risk of mortality. Despite the very large number of individuals included in this study, numbers in extreme high HDL cholesterol groups were small, limiting statistical power, especially in stratified analyses and in analyses of cause-specific mortality, and affecting model fit at these extremes. Finally, as we only included white individuals of Danish descent, results may not necessarily be generalizable to other geographical regions or ethnicities; however, we are unaware of studies indicating that the present findings would not apply elsewhere and in other ethnicities.
A primary strength of the present study is the large number of prospectively recruited individuals from the general population. Second, we investigated the full range of HDL cholesterol concentrations, using both splines and categories based on concentrations and percentiles. Third, we had detailed information on several confounders with known effect on mortality. Fourth, use of the Danish registries ensured complete follow-up and complete information on death. Last, in the main analyses, data from two studies was combined to obtain maximum statistical power; however, results were similar in the Summarizing Figure HDL cholesterol and risk of all-cause mortality in the general population. Based on 52 268 men and 64 240 women from the Copenhagen General Population Study and the Copenhagen City Heart Study combined. Hazard ratio (solid line) and 95% confidence interval (dashed lines) from age and study adjusted Cox regression using restricted cubic splines. The concentration of HDL cholesterol associated with lowest mortality was used as reference. The light blue area indicates the distribution of HDL cholesterol concentrations in men and women. CI, confidence interval; HDL, high-density lipoprotein.
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